SCHEMBL4618586

SCHEMBL4618586

CCN(CC)CCCNS(=O)(=O)c1cc(S(=O)(=O)c2ccc(F)cc2)ccc1C

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.52
USP2 O75604 1/20 0.52
L3MBTL3 Q96JM7 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
KMT2A Q03164 1/20 0.47
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616164 0.93 SFRP1 (0.54) SFRP1ALDH1A1KMT2ASIGMAR1
SCHEMBL4616943 0.90 SFRP1 (0.65) SFRP1USP2L3MBTL3SIGMAR1NPSR1
SCHEMBL4618414 0.88 SFRP1 (0.61) SFRP1MEN1ALDH1A1PKMKMT2A
SCHEMBL4616704 0.83 SFRP1 (0.56) SFRP1MEN1ALDH1A1PKMKMT2A
SCHEMBL4618283 0.82 SFRP1 (0.68) SFRP1ALDH1A1KMT2ASIGMAR1
SCHEMBL4618116 0.81 SFRP1 (0.54) SFRP1USP2MEN1ALDH1A1PKM
SCHEMBL4618887 0.80 SFRP1 (0.75) SFRP1MEN1ALDH1A1PKMKMT2A
SCHEMBL4617259 0.79 SMN1; SMN2 (0.56) SFRP1USP2MEN1ALDH1A1PKM
SCHEMBL4617223 0.79 SFRP1 (0.64) SFRP1MEN1ALDH1A1PKMKMT2A
SCHEMBL4617084 0.78 SFRP1 (0.81) SFRP1USP2L3MBTL3ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885USP2 2796/4885L3MBTL3 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.